Allogene Therapeutics Inc (NAS:ALLO)
$ 2.02 -0.12 (-5.61%) Market Cap: 448.70 Mil Enterprise Value: 252.75 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 36/100

Allogene Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 11:20PM GMT
Release Date Price: $6.36 (+2.09%)
Perry Ezra Mayo;Malasky
BofA Securities, Research Division - Research Analyst

So hi, everyone. My name is Perry. Mayo-Malasky. I'm one of the analysts here at Bank of America on Jason Gerberry's team, who covers SMID biotech and specialty pharma. I'm pleased to introduce our next guest, Allogene Therapeutics. I'm here with CFO, Eric Schmidt. Eric, welcome.

Eric Thomas Schmidt
Allogene Therapeutics, Inc. - Executive VP & CFO

Perry, thanks so much for having us here. I remember last year, this was sort of the first coming-out party on Wall Street post-COVID. And today, it's just been a pleasure to see the activity in the hallways and elevator banks and feel like really the world is back to life. So terrific opportunity for us.

Perry Ezra Mayo;Malasky
BofA Securities, Research Division - Research Analyst

Yes, absolutely. And it's great to be here in person.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot